- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our monthly e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Authors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- David Thomas
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Timothy Coetzee
- Tracy Cooley
Tags
Partnering ethanol Greenhouse Gas Emission BIO Investor Forum greenhouse gas emissions indirect land use change global food crisis biotechnology agriculture Animal biotechnology renewable fuel standard Biofuel Technology Food and Fuel Benefits of biotech crops Plant biotechnology BIO One-on-One's Food Climate Change
Tag Archives: patents
Celebrating 30 Years of Biotechnology Innovation: From Diamond v. Chakrabarty to Today
David Kappos, Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO), provided opening remarks at an event entitled, Celebrating 30 years of Biotechnology Innovation: From Diamond v. Chakrabarty to Today during the 2011 BIO International Convention. The forum, co-sponsored by the US Patent and Trademark Office, The Biotechnology Industry Organization and the Biojudiciary Project, celebrated the 30th anniversary of the issuance of the patent from the Supreme Read More >
USTR: TPP to have High IP Standards to “Stand Alongside other Treaty Agreements in the Area”
Stan McCoy, Assisant U.S. Trade Representative for Intellectual Property and Innovation, spoke at BIO’s 2011 Convention session titled The Trans-Pacific Partnership and the Importance of Intellectual Property Rights: Attracting Investment in Biotechnology. The session covered the ongoing treaty negotiations and the relevance of different IP provisions to the biotechnology industry. Issues of particular importance to the biotechnology industry yet to be revelead to the public include language tabled for data protection and patent linkage. While USTR specific language is not available, Read More >
Patents in the U.S. Supreme Court
A special session at the 2011 BIO International Convention takes a fascinating look at the underlying factors involved in the U.S. Supreme Court hearing patent cases. The Supreme Court has been accepting patent cases at a higher rate than ever before, with three major patent appeals reviewed this past term alone. And the Court seems poised to accept several more in the coming year. According to the session moderator, Chief Judge (Ret.) Paul Michel from Read More >
Blogging from #BIO2011
by Stephen Albainy-Jenei, from Patent Baristas You can keep up with what’s happening at BIO 2011 on BIOTechNOW (@BIOTechNOW) plus all the BIO Official Bloggers hitting the floor at the convention. I’ll be in attendance as well as participating in the BIO Official Blogger network throughout the week. If you’d like to meet up during the conference, drop me a note and we’ll schedule some time to have coffee together.
Docs at BIO: Patent Litigation Tactics and Strategies for Biosimilars
One of the highlights of the afternoon sessions at the BIO International Convention was a seminar appropriately entitled “A Brave New World: Patent Litigation Tactics and Strategies for Biosimilars,” where an experienced panel of patent attorneys presented their interpretation of the new biosimilars pathway of the Biologics Price Competition and Innovation Act and speculated on some of the potential issues that will arise once the statute is put into practice. From Patent Docs.
